| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
— | — | — |
|
NII / HNI
|
Over 1.00x
|
— | — | — |
|
Retail
|
Over 1.00x
|
— | — | — |
| Total | 1.00x | — |
100% | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 26 | ₹28,158 |
| Retail (Max — 14 Lots) | 14 | 182 | ₹197,106 |
| S-HNI (Min — 15 Lots) | 15 | 195 | ₹211,185 |
| B-HNI (Min — 72 Lots) | 72 | 936 | ₹1,013,688 |
Tatva Chintan Pharma Chem Ltd. is proposing an IPO on NSE & BSE under the Mainboard category.
Opens 16 Jul 2021, closes 20 Jul 2021. Listing: 28 Jul 2021. Apply via ASBA or UPI.
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Borrowings | N/A | N/A | N/A |
| EBITDA Margin (%) | N/A | — | — |
| PAT Margin (%) | N/A | — | — |
Tatva Chintan Pharma Chem Ltd. IPO is subscribed 1.00 times by Jul 20, 2021. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Tatva Chintan Pharma Chem Ltd. IPO retail category is subscribed 1.00 times as of 20 Jul 2021. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 16 Jul 2021 and closes 20 Jul 2021. Min investment: ₹14,079 (1 lot = 13 shares). UPI mandate: 5:00 PM on 20 Jul 2021.
The Tatva Chintan Pharma Chem Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 26 Jul 2021. Refunds: on 27 Jul 2021.
The Tatva Chintan Pharma Chem Ltd. IPO listing date is 28 Jul 2021, Wednesday. Listed on: NSE & BSE. Issue price: ₹1,083. Estimated listing: ₹1,083. GMP: NIL.
The Tatva Chintan Pharma Chem Ltd. IPO closes on 20 Jul 2021, Tuesday. UPI mandate: 5:00 PM on 20 Jul 2021. Allotment: 26 Jul 2021. Listing: 28 Jul 2021.